SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: David Winkler who wrote (975)5/12/1998 9:23:00 AM
From: epicure  Respond to of 2135
 
>So we have a company that can prevent blindness in babies, old folks and cure cancer and folks get in line to short it at 30 certain it will go back to 12 while others pay $60+ per share.<

If they were close to actually doing any of this stuff you would be right. But it would be better to say "we have a company that MAY in the future be able to prevent blindness, cure cancer...yada yada"



To: David Winkler who wrote (975)5/12/1998 9:27:00 AM
From: Jason Loren Bauer  Respond to of 2135
 
I called the company about earnings. The guy who answered said the company wasn't even sure when they would release earnings (Tues or Wed) and they didn't know if it would be before market close or after. It must be real hard adding up all those negative numbers. It looks like ENMD's investor relation department is about as efficient as the PR department.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News